373 related articles for article (PubMed ID: 10082881)
1. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala.
Carr KD; Kutchukhidze N; Park TH
Brain Res; 1999 Mar; 822(1-2):34-42. PubMed ID: 10082881
[TBL] [Abstract][Full Text] [Related]
2. Neuroanatomical patterns of Fos-like immunoreactivity induced by naltrexone in food-restricted and ad libitum fed rats.
Carr KD; Park TH; Zhang Y; Stone EA
Brain Res; 1998 Jan; 779(1-2):26-32. PubMed ID: 9473572
[TBL] [Abstract][Full Text] [Related]
3. The dynamic relationship between mu and kappa opioid receptors in body temperature regulation.
Chen X; McClatchy DB; Geller EB; Tallarida RJ; Adler MW
Life Sci; 2005 Dec; 78(4):329-33. PubMed ID: 16257420
[TBL] [Abstract][Full Text] [Related]
4. Neuroanatomical patterns of fos-like immunoreactivity induced by a palatable meal and meal-paired environment in saline- and naltrexone-treated rats.
Park TH; Carr KD
Brain Res; 1998 Sep; 805(1-2):169-80. PubMed ID: 9733960
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats.
Steinmiller CL; Young AM
Psychopharmacology (Berl); 2008 Jan; 195(4):497-507. PubMed ID: 17882404
[TBL] [Abstract][Full Text] [Related]
6. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain.
Bot G; Chahl LA
Brain Res; 1996 Aug; 731(1-2):45-56. PubMed ID: 8883853
[TBL] [Abstract][Full Text] [Related]
7. Effects of mu and kappa opioid receptor antagonists on glucoprivic induction of Fos immunoreactivity in the rat preoptic area and hypothalamus.
Briski KP; Teodecki L
Brain Res Bull; 1999 Jun; 49(3):181-7. PubMed ID: 10435781
[TBL] [Abstract][Full Text] [Related]
8. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
9. Interaction of cholecystokinin and somatostatin with a selective mu-opioid agonist and mu- and kappa-antagonists in thermoregulation.
Ghosh S; Geller EB; Adler MW
Brain Res; 1997 Jan; 745(1-2):152-7. PubMed ID: 9037404
[TBL] [Abstract][Full Text] [Related]
10. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
[TBL] [Abstract][Full Text] [Related]
11. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
Le Guen S; Gestreau C; Besson JM
Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
[TBL] [Abstract][Full Text] [Related]
12. Identification of central sites involved in butorphanol-induced feeding in rats.
Kim EM; Shi Q; Olszewski PK; Grace MK; O'Hare E; Billington CJ; Levine AS
Brain Res; 2001 Jul; 907(1-2):125-9. PubMed ID: 11430893
[TBL] [Abstract][Full Text] [Related]
13. Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus.
Osaki MY; Castellan-Baldan L; Calvo F; Carvalho AD; Felippotti TT; de Oliveira R; Ubiali WA; Paschoalin-Maurin T; Elias-Filho DH; Motta V; da Silva LA; Coimbra NC
Brain Res; 2003 Dec; 992(2):179-92. PubMed ID: 14625057
[TBL] [Abstract][Full Text] [Related]
14. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions.
Bodnar RJ; Glass MJ; Ragnauth A; Cooper ML
Brain Res; 1995 Nov; 700(1-2):205-12. PubMed ID: 8624711
[TBL] [Abstract][Full Text] [Related]
15. The role of multiple opioid receptors in the potentiation of reward by food restriction.
Carr KD; Papadouka V
Brain Res; 1994 Mar; 639(2):253-60. PubMed ID: 8205479
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of galanin in the central nucleus of amygdala of rats, an involvement of opioid receptors.
Jin WY; Liu Z; Liu D; Yu LC
Brain Res; 2010 Mar; 1320():16-21. PubMed ID: 20051236
[TBL] [Abstract][Full Text] [Related]
17. Analysis of opioid receptor subtype antagonist effects upon mu opioid agonist-induced feeding elicited from the ventral tegmental area of rats.
Lamonte N; Echo JA; Ackerman TF; Christian G; Bodnar RJ
Brain Res; 2002 Mar; 929(1):96-100. PubMed ID: 11852035
[TBL] [Abstract][Full Text] [Related]
18. Cocaine reward and hyperactivity in the rat: sites of mu opioid receptor modulation.
Soderman AR; Unterwald EM
Neuroscience; 2008 Jul; 154(4):1506-16. PubMed ID: 18550291
[TBL] [Abstract][Full Text] [Related]
19. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
[TBL] [Abstract][Full Text] [Related]
20. The first suckling episode in the rat: the role of endogenous activity at mu and kappa opioid receptors.
Petrov ES; Varlinskaya EI; Smotherman WP
Dev Psychobiol; 2000 Nov; 37(3):129-43. PubMed ID: 11044861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
